Cargando…

Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan

BACKGROUND: Bronchopulmonary dysplasia (BPD) is the most common complication of preterm birth with short-term and long-term adverse consequences. Although the glucocorticoid dexamethasone has been proven to be beneficial for the prevention of BPD, there are concerns about an increased risk of advers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onland, Wes, Merkus, Maruschka P., Nuytemans, Debbie H., Jansen-van der Weide, Marijke C., Holman, Rebecca, van Kaam, Anton H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845134/ https://www.ncbi.nlm.nih.gov/pubmed/29523175 http://dx.doi.org/10.1186/s13063-018-2505-y

Ejemplares similares

Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
por: Onland, Wes, et al.
Publicado: (2011)

Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study)
por: Balink, Stephanie, et al.
Publicado: (2022)

Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms
por: Chen, Xin, et al.
Publicado: (2019)

Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
por: Omar, Said A., et al.
Publicado: (2022)

The association between clinical and biochemical characteristics of late-onset sepsis and bronchopulmonary dysplasia in preterm infants
por: Ebrahimi, Melania E., et al.
Publicado: (2021)

Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan
por: Hundscheid, Tim, et al.
Publicado: (2021)

Systemic Steroids in Preventing Bronchopulmonary Dysplasia (BPD): Neurodevelopmental Outcome According to the Risk of BPD in the EPICE Cohort
por: Zayat, Noura, et al.
Publicado: (2022)

Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice
por: Das, Pragnya, et al.
Publicado: (2021)

Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD)
por: Löfqvist, Chatarina, et al.
Publicado: (2012)

Hydrocortisone and bronchopulmonary dysplasia: variables associated with response in premature infants
por: Clauss, Christie, et al.
Publicado: (2020)

Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study
por: van Katwyk, Sasha, et al.
Publicado: (2020)

Towards a harmonized bronchopulmonary dysplasia definition: a study protocol for an international Delphi procedure
por: Katz, Trixie A, et al.
Publicado: (2023)

Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction
por: Pels, Anouk, et al.
Publicado: (2019)

Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial
por: Francis, Kate L, et al.
Publicado: (2023)

Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program
por: Wang, Xuting, et al.
Publicado: (2022)

Respiratory Morbidity and Lung Function Analysis During the First 36 Months of Life in Infants With Bronchopulmonary Dysplasia (BPD)
por: Chen, Dandan, et al.
Publicado: (2020)

A comparison of newer classifications of bronchopulmonary dysplasia: findings from the Children’s Hospitals Neonatal Consortium Severe BPD Group
por: Vyas-Read, Shilpa, et al.
Publicado: (2021)

New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks
por: Geetha, Odattil, et al.
Publicado: (2021)

Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study
por: Onland, Wes, et al.
Publicado: (2013)

Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update
por: Nuytemans, Karen, et al.
Publicado: (2010)

Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System †
por: Chao, Cho-Ming, et al.
Publicado: (2020)

Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis
por: Lan, Jiang, et al.
Publicado: (2023)

BPD, Not BPD, or Iatrogenic BPD: Findings of Lung Ultrasound Examinations
por: Liu, Jing, et al.
Publicado: (2014)

Stop that! It’s not Tourette’s but a new type of mass sociogenic illness
por: Müller-Vahl, Kirsten R, et al.
Publicado: (2021)

Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis
por: Morris, Ian Paul, et al.
Publicado: (2019)

Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial
por: He, Yuan, et al.
Publicado: (2020)

Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic
por: Ruran, Hana B, et al.
Publicado: (2021)

The high-risk factors of different severities of bronchopulmonary dysplasia (BPD) based on the national institute of child health and human development (NICHD) diagnosis criteria in 2018
por: Jian, Minqiao, et al.
Publicado: (2021)

Starting the SToP trial: Lessons from a collaborative recruitment approach
por: McRae, Tracy, et al.
Publicado: (2022)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Sto. Tomás
por: Bretón, Stanislas
Publicado: (1976)

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial
por: Al-Shahi Salman, Rustam, et al.
Publicado: (2019)

Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial)
por: Wu, Xian, et al.
Publicado: (2020)

Vitamin D and bronchopulmonary dysplasia in preterm infants
por: Joung, K E, et al.
Publicado: (2016)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Statistical analysis plan for the Healthy Hands Project; single centre cluster-randomised clinical trial of a skin care program for the prevention of contact dermatitis in health care workers
por: Soltanipoor, Maryam, et al.
Publicado: (2018)

DYSPLASIA OF HIP DEVELOPMENT: UPDATE
por: Guarniero, Roberto
Publicado: (2015)

Yoghurt Intake and Gastric Cancer: A Pooled Analysis of 16 Studies of the StoP Consortium
por: Collatuzzo, Giulia, et al.
Publicado: (2023)

Promoting Recruitment using Information Management Efficiently (PRIME): statistical analysis plan for a stepped wedge cluster randomised trial within the REstart or STop Antithrombotics Randomised Trial (RESTART)
por: Parker, Richard A., et al.
Publicado: (2017)

Two-year clinical follow-up of the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in The Netherlands (MR CLEAN): design and statistical analysis plan of the extended follow-up study
por: van den Berg, Lucie A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sas3pihvafa62ea47qdjfbspe1